Re: 2019 Potential Events
|
6
|
Resverlogix Corp.
|
Sep 16, 2019 03:11PM
|
Re: Now published: Rationale, design, and baseline characteristics of the BETonMACE trial
|
2
|
Resverlogix Corp.
|
Sep 16, 2019 03:05PM
|
Re: Now published: Rationale, design, and baseline characteristics of the BETonMACE trial
|
8
|
Resverlogix Corp.
|
Sep 16, 2019 02:21PM
|
Re: Zenith Announces Annual and Special Meeting of Shareholders
|
4
|
Zenith Epigenetics
|
Sep 16, 2019 02:01PM
|
Re: Contest
|
5
|
Resverlogix Corp.
|
Sep 16, 2019 12:57PM
|
Resverlogix Provides Update on BETonMACE Phase 3 Trial
|
6
|
Resverlogix Corp.
|
Sep 16, 2019 08:44AM
|
Re: I thought we'd have some news on the loan today....
|
4
|
Resverlogix Corp.
|
Sep 14, 2019 05:17PM
|
Re: Intellectually versus emotionally
|
3
|
Resverlogix Corp.
|
Sep 14, 2019 05:08PM
|
Re: I thought we'd have some news on the loan today....
|
5
|
Resverlogix Corp.
|
Sep 13, 2019 10:39PM
|
Re: Intellectually versus emotionally
|
1
|
Resverlogix Corp.
|
Sep 13, 2019 10:20PM
|
Re: I thought we'd have some news on the loan today....
|
2
|
Resverlogix Corp.
|
Sep 13, 2019 08:48PM
|
Re: Fun and games on StockTwits...
|
7
|
Resverlogix Corp.
|
Sep 13, 2019 03:40PM
|
New RVX Blog Post: Balancing Epigenetics in the Treatment of Chronic Kidney Disease
|
3
|
Resverlogix Corp.
|
Sep 13, 2019 02:39PM
|
Re: Statistically proven...
|
2
|
Resverlogix Corp.
|
Sep 13, 2019 02:04PM
|
Re: I thought we'd have some news on the loan today....
|
6
|
Resverlogix Corp.
|
Sep 13, 2019 01:58PM
|
Re: Statistically proven...
|
3
|
Resverlogix Corp.
|
Sep 12, 2019 10:46PM
|
Re: Statistically proven...
|
4
|
Resverlogix Corp.
|
Sep 12, 2019 10:34PM
|
Re: Use of Caps Lock is not permitted
|
3
|
Resverlogix Corp.
|
Sep 12, 2019 04:29PM
|
Re: Seeming lack of interest
|
7
|
Resverlogix Corp.
|
Sep 12, 2019 09:44AM
|
AGM Notice of Meeting on or about September 30
|
4
|
Resverlogix Corp.
|
Sep 12, 2019 06:52AM
|